This document discusses different modalities for treating acute kidney injury (AKI) in critically ill patients, including continuous renal replacement therapy (CRRT) and intermittent hemodialysis. It provides pros and cons of each modality and factors to consider in determining the optimal treatment for an individual patient. While CRRT allows for more gradual fluid removal and hemodynamic stability, clearance is better with intermittent therapies. The document concludes that hemodynamic stability is the main determinant of treatment choice and clearance is optimized through combination of diffusion and convection methods.
3. • Modality: The main mechanism with which
clearance is achieved.
Prof. Yasser Abdelhamid
4. Ideal Treatment Modality
• Preserves homeostasis
• Does not increase co-morbidity
• Does not worsen patient’s underlying
condition
• Inexpensive
• Simple to manage
• Not burdensome to the ICU staff
Prof. Yasser Abdelhamid
5. • 80% of patients with AKI in the ICU were
treated with continuous therapies,
• 17% with intermittent Therapies
• 3% with peritoneal dialysis or slow continuous
ultrafiltration
(Uchino et al, Intensive Care Med, 2007)
Prof. Yasser Abdelhamid
14. • Gradual removal of solutes and metabolic
waste helps to clear inflammatory mediators
and ensure adequate nutrition for patients
Prof. Yasser Abdelhamid
15. Intermittent Hemodialysis
Short duration
less anticoagulation
Higher efficiency
Less bed rest
Flexible
Bags cost saving
Dialysate
Infrastructure
Rebound
Hemodynamic
instability
Residual renal
functions
Prof. Yasser Abdelhamid
18. Why
• Maintenance of intravascular compartment volume
• Prolonged treatments permit lower fluid removal rates
– IHD: 3 L in 3 hours = 1 L/h UF rate
– CRRT: 3 L in 24 hrs = 0.125 ml/h UF rate
• Urea diffusion is faster with IHD than CRRT
– IHD: Urea clearance ~160 ml/min
– CRRT: Urea clearance ~15-30 ml/min
• Convective sodium removal rate
[hemofiltration/hemodiafiltration] is less than diffusive
removal rate [hemodialysis]
• Decreased core temperature.
• Convective removal of inflammatory mediators could
contribute to hemodynamic stability.
Prof. Yasser Abdelhamid
19. • Cardiac failure.
• Large amount of IV intake.
• Hyperthermia (core temperature >39.5°C) or
hypothermia (core temperature <37°C)
• Overdose with a dialyzable toxin (e.g. Lithium)
Prof. Yasser Abdelhamid
Non Renal Indications (ICU)
20. • Combined acute renal and hepatic failure
• Acute brain injury: Decreases cerebral edema
– Autoregulation is lost!
– Sudden changes in systemic or intra-abdominal
pressure change intracranial pressure
– Slow correction of azotemia
• Na disorders
• Abdominal compartment syndrome
Non Renal Indications
Prof. Yasser Abdelhamid
21. Special Circumstances
• Acute fulminant liver failure:
– Brain edema.
– Hyponatremia is common, causes brain edema
Prof. Yasser Abdelhamid
23. • Many intensivists and nephrologists prefer to
use CVVH in the belief that pure convection
will remove a greater number of larger
molecules than diffusion-base CVVHD.
• CVVHDF in a safe combination
(Ricci et al, Crit Care, 2006)
Prof. Yasser Abdelhamid
24. • Initially, high volume hemofiltration offered
benefit over conventional hemodialysis.
• Meta-analysis (IVOIRE) suggested no
benefit (Borthwick et al, Cochrane Database Syst Rev. 2013, Joannes-Boyau et
al Intensive Care Med. 2013)
• High dose 80ml/kg/h was found to decrease level
of IL 1B, 6, 8 and 10 with no effect on mortality
than conventional dos of 40ml/kg/h
(Park et al, Am J Kidney Dis, 2016)
Prof. Yasser Abdelhamid
CRRT and Sepsis
25. Modality Choice
o IHD # CRRT
o SLEDD # CRRT
o IHD # PD
o SLEDD # PD
o CRRT # PD
Prof. Yasser Abdelhamid
26. Slower (QD,QB).
Prolonged >5 h.
Hemodynamic tolerance.
• 6–12 hours over night treatment.
• Patient mobility
Anticoagulation.
Superior clearance than CRRT,
Removal of toxins (higher flows)
Prof. Yasser Abdelhamid
Advantages
27. Disadvantages
• Same as IHD
• Hypophosphatemia.
• Hypothermia.
• Low efficiency.
Prof. Yasser Abdelhamid
28. Hybrid Methods
• Operational characteristics
• Fluid removal: ultrafiltration volumes vary
between zero and 6 L /d
• Electrolyte control and nutritional
considerations: maintained within normal limits.
• Protein should be augmented by 0.2 gm/kg per
day during hybrid treatment.
• Drug clearance: intermediate between that of
IHD and CRRT.
Prof. Yasser Abdelhamid
30. Hybrid Methods (PIRTT)
Reported experiences suggest patients
outcomes are similar to those reported with
other acute therapies.
Prof. Yasser Abdelhamid
Outcome
s
32. • Conclusion:
• SLEDD is a viable modality of renal
replacement therapy in patients with septic
shock as the hemodynamic effects are similar
to CRRT.
Prof. Yasser Abdelhamid
33. Sepsis associated AKI
Use of Norepinephrin
194 pt , 531 sessions
No difference in mortality
or renal recovery
Prof. Yasser Abdelhamid
34. Modality Choice
o IHD # CRRT
o SLEDD # CRRT
o IHD # PD
o SLEDD # PD
o CRRT # PD
Prof. Yasser Abdelhamid
38. Acute Kidney Injury in Critically Ill Patients: A Prospective Randomized Study of Tidal Peritoneal Dialysis Versus Continuous R
Replacement Therapy
Acute Kidney Injury in Critically Ill Patients: A Prospective Randomized Study of Tidal Peritoneal Dialysis Versus Continuous Renal Replacement Therapy, Volume: 22, Issue:
4, Pages: 371-379, First published: 25 March 2018, DOI: (10.1111/1744-9987.12660)
39. Acute Kidney Injury in Critically Ill Patients: A Prospective Randomized Study of Tidal Peritoneal Dialysis Versus Continuous Renal Replacement Therapy, Volume: 22, Issue:
4, Pages: 371-379, First published: 25 March 2018, DOI: (10.1111/1744-9987.12660)
42. • Comparison of
metabolic and fluid
control in daily
extended hemodialysis
(EHD) and high volume
peritoneal dialysis
(Researchgate)
Prof. Yasser Abdelhamid
BUN
Creat
Bicab
K
UF Kt/V
44. • CONCLUSIONS:
• Based on moderate (mortality, recovery of kidney
function), low (infectious complications), or very
low certainty evidence (correction of acidosis)
there is probably little or no difference between
PD and extracorporeal therapy for treating AKI.
Fluid removal (low certainty) and weekly
delivered Kt/V (very low certainty) may be higher
with extracorporeal therapy.
Prof. Yasser Abdelhamid
45. • Hemodynamic stability of the critically ill
patient is the main determinant of the choice
of dialysis modality
(Palevsky et al, N Engl J Med, 2008)
Prof. Yasser Abdelhamid
46. Criteria of Different Therapies
(Cerda´ and Ronco, Seminars in Dialysis, 2009)Prof. Yasser Abdelhamid
53. Renal Recovery
• Forty-nine studies were included
• Conclusion: Findings of the conducted
assessment show that initial CRRT is
associated with higher rates of renal recovery.
Prof. Yasser Abdelhamid
54. RRT and Recovery
• Decision to initiation:
• No clear effect on short and long term
recovery
• (Clec’h C, et al, Crit Care, 2011)
• (Elseviers et al, Crit Care, 2010)
• (Bagshaw et al, J Crit Care, 2013) BEST
Prof. Yasser Abdelhamid
55. Initial therapy, at least with CRRT, may confer
a higher likelihood of recovery to dialysis
independence
(Wald et al, Crit Care Med. 2014)
(Glassford et al, Curr OpinCrit Care 2011)
(Schneider et al, Intensive Care Med 2013)
RENAL and ATN (the reverse)
RRT and Recovery
Prof. Yasser Abdelhamid
56. Impact on Modality on Recovery
(Schneider and Bagshaw, Nephron Clin Pract 2014)Prof. Yasser Abdelhamid
Definition
of
Recovery
57. Do You Trust?
• IRRT: Lower illness severity
• IRRT: Greater hemodynamic stability
• Impact of original disease.
• Other treatments.
Prof. Yasser Abdelhamid
58. End Point of Recovery
• 30 d survival
• 90 d survival
• ICU stay
• RRT dependence
• 6m, 12 m survival
• RIFLE improvement
Prof. Yasser Abdelhamid
59. • Retrospective cohort
• 2000 to 2008 who received RRT for AKI and
survived to hospital discharge or 90 days
• 4738 pt AKI KDIGO 3
• 638 (47.7%) survived to hospital discharge
• Renal recovery (alive and not requiring RRT
• 90 and 365 days.
Prof. Yasser Abdelhamid
60. • No significant difference in hazards for non-
recovery or reasons for non-recovery
(mortality or ESRD) with intermittent
hemodialysis versus continuous RRT
Prof. Yasser Abdelhamid
62. • CRRT did not appear to improve 30-day and 6-
month patient outcomes. It seems beneficial
for patients with fluid overload, but might be
deleterious in the absence of hemodynamic
failure. (Truche et al ,Intensive Care Medicine, 2016)
Prof. Yasser Abdelhamid
64. • Hemodynamic stability is the main determinant
of modality choice.
• Clearance is better achieved by combination of
diffusion and convection.
• Specific indications for CRRT.
• Volume overload and renal recovery.
• CRRT and recovery ???
Prof. Yasser Abdelhamid